序号 |
CAS |
半岛bd体育手机客户端 名称 |
规格 |
包装 |
参考价格 |
1 |
2632-13-5 |
PTP inhibitor 1 |
≥98% |
50mg, 100mg, 250mg |
询价 |
2 |
6192-52-5 |
p-Toluenesulfonic acid monohydrate |
≥98% |
50mg, 100mg, 250mg |
询价 |
3 |
861446-16-4 |
Resveratrol analog 1 |
≥98% |
50mg, 100mg, 250mg |
询价 |
4 |
74298-63-8 |
Chlormidazole HCl |
≥98% |
50mg, 100mg, 250mg |
询价 |
5 |
2083621-91-2 |
MBM-17S |
≥98% |
50mg, 100mg, 250mg |
询价 |
6 |
2204226-02-6 |
Thalidomide-O-amido-PEG-C2-NH2 HCl |
≥98% |
50mg, 100mg, 250mg |
询价 |
7 |
2376990-31-5 |
Thalidomide-O-amido-C6-NH2 HCl |
≥98% |
50mg, 100mg, 250mg |
询价 |
8 |
|
Thalidomide-O-amido-C8-NH2 HCl |
≥98% |
50mg, 100mg, 250mg |
询价 |
9 |
501081-38-5 |
FGI-106 |
≥98% |
|
询价 |
10 |
1037-50-9 |
Sulfadimethoxine sodium |
≥98% |
50mg, 100mg, 250mg |
询价 |
11 |
1069622-60-1 |
MCHR1 antagonist 3 |
≥98% |
50mg, 100mg, 250mg |
询价 |
12 |
925213-80-5 |
GSK269962A 3HCl |
≥98% |
|
询价 |
13 |
392711-19-2 |
Rapamycin-d3 |
≥98% |
|
询价 |
14 |
1314021-57-2 |
ARQ 069 |
≥98% |
50mg, 100mg, 250mg |
询价 |
15 |
1426174-41-5 |
Ezetimibe phenoxy glucuronide-D4 |
≥98% |
|
询价 |
16 |
2341796-76-5 |
(S,R,S)-AHPC-PEG2-NH2 diHCl |
≥98% |
50mg, 100mg, 250mg |
询价 |
17 |
59450-89-4 |
Calcimycin hemicalcium salt |
≥98% |
|
询价 |
18 |
2102101-72-2 |
IPN-60090 diHCl |
≥98% |
|
询价 |
19 |
1783987-80-3 |
CYM5442 HCl |
≥98% |
50mg, 100mg, 250mg |
询价 |
20 |
848035-21-2 |
Compound 48/80 triHCl |
≥98% |
50mg, 100mg, 250mg |
询价 |
21 |
2095432-39-4 |
MRT67307 HCl |
≥98% |
|
询价 |
22 |
140909-80-4 |
Serrawettin W2 |
≥98% |
|
询价 |
23 |
56-41-7 |
alanine |
≥98% |
|
询价 |
24 |
1254205-52-1 |
RQ-00203078 |
≥98% |
|
询价 |
25 |
706809-20-3 |
Alalevonadifloxacin |
≥98% |
|
询价 |
26 |
61-40-5 |
AQ 1989 |
≥98% |
|
询价 |
27 |
911378-38-6 |
RBI-257 Maleate |
≥98% |
|
询价 |
28 |
117-89-5 |
Trifluoperazine(TFP SKF5019) |
≥98% |
|
询价 |
29 |
5352-53-4 |
BPH-1358 |
≥98% |
|
询价 |
30 |
135410-20-7 |
Acetamiprid |
≥98% |
|
询价 |
31 |
37517-28-5 |
Amikacin free base |
≥98% |
|
询价 |
32 |
4966-13-6 |
Lambertianic acid |
≥98% |
|
询价 |
33 |
199396-76-4 |
Asoprisnil |
≥98% |
|
询价 |
34 |
124-76-5 |
Isoborneol |
≥98% |
|
询价 |
35 |
203737-94-4 |
PST2774 oxalate |
≥98% |
|
询价 |
36 |
920113-03-7 |
Riviciclib HCl(P276-00) |
≥98% |
|
询价 |
37 |
99260-65-8 |
Saquayamycin |
≥98% |
|
询价 |
38 |
16844-71-6 |
Epifriedelanol |
≥98% |
|
询价 |
39 |
81489-64-7 |
Ascorbyl nicotinate |
≥98% |
|
询价 |
40 |
124495-31-4 |
8-Chloro-4-(2-chloro-4-fluorophenoxy)quinoline |
≥98% |
|
询价 |
41 |
132-69-4 |
Benzydamine hydrochloride |
≥98% |
|
询价 |
42 |
24390-12-3 |
Fantridone HCl |
≥98% |
|
询价 |
43 |
910562-18-4 |
Aganepag |
≥98% |
|
询价 |
44 |
|
DREADD agonist 21 diHCl |
≥98% |
50mg, 100mg, 250mg |
询价 |
45 |
84176-65-8 |
Antimalarial agent 1 |
≥98% |
|
询价 |
46 |
2140301-98-8 |
PF-04634817 succinate |
≥98% |
50mg, 100mg, 250mg |
询价 |
47 |
137433-23-9 |
(R)-Hydroxychloroquine |
≥98% |
|
询价 |
48 |
2093386-51-5 |
Thalidomide-NH-C6-NH2 TFA |
≥98% |
50mg, 100mg, 250mg |
询价 |
49 |
137433-24-0 |
(S)-Hydroxychloroquine |
≥98% |
|
询价 |
50 |
|
TNO155 HCl |
≥98% |
|
询价 |
51 |
|
HBC599 |
≥98% |
50mg, 100mg, 250mg |
询价 |
52 |
|
HBC620 |
≥98% |
50mg, 100mg, 250mg |
询价 |
53 |
328076-61-5 |
Ceranib1 |
≥98% |
50mg, 100mg, 250mg |
询价 |
54 |
479413-68-8 |
CUDA |
≥98% |
|
询价 |
55 |
547-32-0 |
Sulfadiazine sodium |
≥98% |
50mg, 100mg, 250mg |
询价 |
56 |
452967-14-5 |
IR415 |
≥98% |
|
询价 |
57 |
28270-04-4 |
Glucagon HCl |
≥98% |
|
询价 |
58 |
1228439-71-1 |
(+)-KCC2 blocker 1 |
≥98% |
50mg, 100mg, 250mg |
询价 |
59 |
484006-66-8 |
β-Glucuronidase-IN-1 |
≥98% |
50mg, 100mg, 250mg |
询价 |
60 |
14348-38-0 |
4-Bromo-3-hydroxybenzoic acid |
≥98% |
50mg, 100mg, 250mg |
询价 |